Tag: IBD treatment
New Once-Monthly UC Treatment Approved: What Patients Need to Know
The FDA has approved Omvoh, the first once-monthly injection for ulcerative colitis maintenance therapy. This breakthrough could significantly reduce treatment burden for people with moderate to severe UC.
25-Year Mystery Solved: Why Your Gut Can’t Heal from Crohn’s
After 25 years of research, scientists have finally identified why Crohn’s disease prevents gut healing—immune cells get stuck in attack mode and can’t hear the signals telling them to start repairing tissue. This breakthrough could lead to targeted therapies that restore your body’s natural healing abilities.
AI Revolution: New Hope for Better IBD Management and Care
Artificial intelligence is revolutionizing IBD care with the potential to predict flares, personalize treatments from the start, and give patients more control over their condition. While still developing, these AI advances represent genuine hope for better management of Crohn’s disease and ulcerative colitis.
The Game-Changing Care Model That’s Reducing IBD ER Visits by 22%
New research shows nurse practitioner-led IBD clinics are reducing emergency room visits by 22% and hospitalizations by 52%. This game-changing care model offers hope for more proactive, accessible IBD management that keeps patients stable and out of crisis.
AI Breakthrough Reveals How Two Proteins Could Protect Against Crohn’s
Cambridge researchers used AI to discover two proteins that work together to protect against Crohn’s disease, opening doors to personalized prevention and treatment approaches. This breakthrough could transform how we understand and manage IBD.
New Clinical Leader Brings Hope to GI Treatment Development
Palisade Bio has appointed Dr. Sharon Skare as VP of Clinical Operations to advance PALI-2108, a promising new GI therapy. Her 30+ years of experience could accelerate development of treatments for conditions with limited options.
Better IBD Treatments on the Horizon: What Growth Means for Patients
Market analysis shows unprecedented growth in IBD research and treatment development, with new biologics, personalized medicine, and digital health platforms on the horizon. Here’s what this expansion means for patients and families managing Crohn’s disease and ulcerative colitis.
New UC Research Tackles Bowel Urgency – The Symptom That Controls Your Life
New clinical trial data shows promising improvements in bowel urgency for ulcerative colitis patients, addressing the symptom that often controls daily life more than any other UC symptom.
New UC Treatment Shows Promise in Just 3 Days
New clinical trial data shows OMVOH, an FDA-approved UC treatment, can start improving symptoms in just three days while maintaining benefits for a full year. This rapid-acting approach could change how we experience UC treatment, offering hope for faster relief and long-term stability.
Could This Overlooked Gut Bacteria Be a Game-Changer for IBD?
New research identifies Ruminococcus torques, a gut bacterium that strengthens the intestinal barrier and may offer new hope for IBD management. This discovery could lead to more targeted, microbiome-based therapies for inflammatory bowel disease.
